Literature DB >> 20202360

Tailoring treatment to risk in type 2 diabetes.

Jonathan Graffy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20202360      PMCID： PMC2828827          DOI： 10.3399/bjgp10X483463

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  11 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

2.  Tight control of blood glucose in long standing type 2 diabetes.

Authors:  Richard Lehman; Harlan M Krumholz
Journal:  BMJ       Date:  2009-03-05

3.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

4.  The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).

Authors:  Gijs W Landman; Kornelis J J van Hateren; Nanne Kleefstra; Klaas H Groenier; Rijk O B Gans; Henk J G Bilo
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

5.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).

Authors:  K T Khaw; N Wareham; R Luben; S Bingham; S Oakes; A Welch; N Day
Journal:  BMJ       Date:  2001-01-06

6.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

7.  Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study.

Authors:  C R Elley; T Kenealy; E Robinson; P L Drury
Journal:  Diabet Med       Date:  2008-11       Impact factor: 4.359

8.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

9.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

10.  Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation.

Authors: 
Journal:  Diabetes Care       Date:  2007-09       Impact factor: 19.112
View more
  1 in total

1.  Impact of community based peer support in type 2 diabetes: a cluster randomised controlled trial of individual and/or group approaches.

Authors:  David Simmons; A Toby Prevost; Chris Bunn; Daniel Holman; Richard A Parker; Simon Cohn; Sarah Donald; Charlotte A M Paddison; Candice Ward; Peter Robins; Jonathan Graffy
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.